Clinical Trials Logo

Clinical Trial Summary

Diabetic Cardiomyopathy (DCM) is disease of myocardial structure and function which is independent of hypertension, coronary heart disease, heart valve abnormalities, and other types of heart disease. DCM affects approximately 12% of diabetics and also appeared in some patients with well-controlled blood glucose. There is no specific and effective diagnostic method of DCM currently. Since it is well known that the dysfunction of myocardial metabolism caused by hyperglycemia and insulin resistance induces DCM, the method of evaluation of the metabolism will assist the diagnosis of DCM.

Nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) is one of important coenzymes involved in biological metabolism. Fluorescence lifetime microscopy (FLIM) can detect the metabolic status based on the fluorescence characteristics of NAD(P)H. Previous studies have reported that NAD(P)H fluorescence lifetime can be used to assess the metabolic status of living cardiomyocytes cultured in vitro, and metabolism changes related to myocardial infarction and heart failure in rats. the investigators detected the metabolic status by label-free FLIM on the myocardial tissues and blood plasma in a rat model of type 2 diabetic cardiomyopathy, and found FLIM could provide valuable information about the myocardial metabolism by detecting the NAD(P)H fluorescence lifetime of blood plasma.

Recently, The investigators have explored the method of the FLIM in clinical study. The investigators used FLIM to compare the NAD(P)H fluorescence lifetime of blood plasma in healthy participants, type 2 diabetic patients with normal diastolic function and with diastolic dysfunction. The results showed that the NAD(P)H fluorescence life parameter of a2 was lower in type 2 diabetic patients with diastolic dysfunction (30.5±2.7%) than in healthy participants (41.5±4.8%) and type 2 diabetic patients with normal diastolic function (37.8±3.7%). Therefore, The investigators propose FLIM can provide valuable information about the myocardial metabolism, and it can be used as a non-invasive, label-free, and rapid screening method of diagnosis of DCM.

In this study, the investigators will recruit 243 patients with type 2 diabetes and divide them into two groups: normal diastolic function group (DM Group) and diastolic dysfunction group (DCM Group), based on the symptoms, laboratory examination and echocardiographic results. Then FLIM will be applied to detect the NAD(P)H fluorescence characteristics of venous blood of all patients. After that, the correlation between the parameters of diastolic function (E peak, E/E' ratio, left atrial volume, NT-proBNP) and the parameters of metabolism status (NAD(P)H fluorescence life parameter of a2 and the ratio of bound state/free state NAD(P)H) will be analyzed. This study will verify FLIM is helpful to diagnose DCM.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04534894
Study type Observational
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact kai guo, doctor
Phone +86-21-25076143
Email guokai@xinhuamed.com.cn
Status Not yet recruiting
Phase
Start date October 1, 2020
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04083339 - Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Phase 3
Recruiting NCT05556005 - Efficacy of Trimetazidine in Diabetic Patients Phase 2
Completed NCT03299790 - Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy N/A
Recruiting NCT03132129 - Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
Recruiting NCT04593173 - Diabetic Cardiomyopathy
Terminated NCT04141475 - Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy N/A
Completed NCT03049228 - In and ex Vivo Mitochondrial Function of the Heart
Completed NCT03930004 - Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
Not yet recruiting NCT05571865 - Diabetic Cardiomyopathy and Heart Failure N/A
Recruiting NCT05958706 - Mitochondrial Substrate Utilization in the Diabetic Human Heart
Recruiting NCT04591639 - The DAPA-MEMRI Trial N/A
Recruiting NCT04826159 - IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) Phase 2
Enrolling by invitation NCT05915260 - CMR in T2DM: The NSR Cohort